Hyperius Biotech

Hyperius Biotech Inc. is a cell & gene therapy venture development organization that utilizes a distinct model featuring a robust ecosystem of strategic partners. We achieve together. The Hyperius approach begins with enabling market-driven, science-based analysis to identify nascent and cutting-edge assets to seed new companies. We are unique in our holistic approach to establishing and nurturing cell & gene therapies and technologies ready for company formation. Assets are incubated and derisked while their capabilities are accelerated together with Hyperius’ strategic partners, including investors, global contract development and manufacturing organizations, leading medical centers, and more. This thorough support is tailored to facilitate both the commercialization of leading-edge cell & gene therapy products and with a clear exit strategy. Our vision is to catalyze innovation at the intersection of science and technology to create a future where leading-edge treatments redefine the possibilities of medical science.